Journal of experimental & clinical cancer research : CR

J Exp Clin Cancer Res · ISSN (e) 1756-9966 · 19 papers in corpus
2023
doi:10.1186/s13046-023-02847-2 ·PMID:37840133

BackgroundLong non-coding RNAs (LncRNAs) have been extensively studied to play essential roles in tumor progression. However, more in-depth studies are waiting to be solved on how lncRNAs regulate the progression of hepatocellular carcinoma…

2022
doi:10.1186/s13046-022-02486-z ·PMID:36114548

Ovarian cancer (OC) is a heterogeneous malignancy with various etiology, histopathology, and biological feature. Despite accumulating understanding of OC in the post-genomic era, the preclinical knowledge still undergoes limited translation…

2021
doi:10.1186/s13046-021-02060-z ·PMID:34452625

Epithelial ovarian cancer (EOC) is the most common gynecologic disorder. Even with the recent progresses made towards the use of new therapeutics, it still represents the most lethal gynecologic malignancy in women from developed countries.…

2020
doi:10.1186/s13046-020-01589-9 ·PMID:32381034

BackgroundThe poor prognosis of patients with ovarian cancer is mainly due to cancer progression. γ-Synuclein (SNCG) has reported as a critical player in cancer metastasis. However, its biological roles and mechanism are yet incompletely un…

2019
doi:10.1186/s13046-019-1488-1 ·PMID:31847864

BackgroundHuman bone marrow mesenchymal stem cells (hBMSCs) are implicated in cancer initiation and metastasis, sometimes by releasing exosomes that mediate cell communication by delivering microRNAs (miRNAs). This study aimed to investigat…

2018
doi:10.1186/s13046-018-0696-4 ·PMID:29458390

BackgroundExtracellular matrix (ECM) is a mediator of tumor progression. However, whether the alterations of the intraperitoneal ECM prior to tumor establishment affects the malignant progression of ovarian cancer remains elusive.MethodsApo…

2017
doi:10.1186/s13046-017-0536-y ·PMID:28482906

BackgroundEpithelial ovarian cancer (EOC) is a spectrum of different diseases, which makes their treatment a challenge. Forkhead box M1 (FOXM1) is an oncogene aberrantly expressed in many solid cancers including serous EOC, but its role in …

2017
doi:10.1186/s13046-017-0568-3 ·PMID:28750679

BackgroundmiR-500a-3p has been demonstrated to be involved in the development, progression and metastasis in several human cancers. Constitutive activation of JAK/STAT3 signaling pathway has been reported to play an important role in the de…

2015
doi:10.1186/s13046-015-0208-8 ·PMID:26362938

BackgroundIt is well-known that the treatment and monitoring methods are limited for advanced stage of endometrial carcinoma. Biological molecules with expression changes during tumor progression become potential therapeutic targets for adv…

2015
doi:10.1186/s13046-015-0161-6 ·PMID:25967040

BackgroundMeasurement of prostate-specific antigen (PSA) advanced the diagnostic and prognostic potential for prostate cancer (PCa). However, due to PSA's lack of specificity, novel biomarkers are needed to improve risk assessment and ensur…

article 2014
doi:10.1186/1756-9966-33-46 ·PMID:24886254

BACKGROUND: The anti-mullerian hormone (AMH) is a member of the transforming growth factor β (TGF-β) superfamily, which is responsible of the regression of the mullerian duct. AMH is expressed in the normal endometrium, where, acting in a p…

2014
doi:10.1186/s13046-014-0060-2 ·PMID:25038792

BackgroundSerous tubal intraepithelial carcinoma (STIC) and the p53 signature in tubal mucosa have been supported to be precursor lesions in high-grade serous carcinoma (HGSC) of the fallopian tube, ovary, and peritoneum. It remains critica…

2013
doi:10.1186/1756-9966-32-39 ·PMID:23759077

BackgroundPrevious evidence has shown that the FOXP3 gene was involved in the pathogenesis of several tumors; however, the correlation between single nucleotide polymorphisms (SNPs) in the FOXP3 gene and the susceptibility to hepatitis B-re…

review 2012
doi:10.1186/1756-9966-31-53 ·PMID:22655678

Several clinical trials to establish standard treatment modality for ovarian cancers included a high abundance of patients with serous histologic tumors, which were quite sensitive to platinum-based chemotherapy. On the other hand, ovarian …

2012
doi:10.1186/1756-9966-31-14 ·PMID:22330607

Ovarian cancer is the most lethal gynecologic malignancy. It appears that the vast majority of what seem to be primary epithelial ovarian and primary peritoneal carcinomas is, in fact, secondary from the fimbria, the most distal part of the…

article 2010
doi:10.1186/1756-9966-29-4 ·PMID:20085636

BACKGROUND: Endometriosis is a common disease characterized by the presence of a functional endometrium outside the uterine cavity, causing pelvic pain, dysmenorrheal, and infertility. This disease has been associated to development of diff…

article 2009
doi:10.1186/1756-9966-28-49 ·PMID:19358700

BACKGROUND: Endometriosis is a gynecological disease defined by the histological presence of endometrial glands and stroma outside the uterine cavity. Women with endometriosis have an increased risk of different types of malignancies, espec…

2008
doi:10.1186/1756-9966-27-59 ·PMID:18983643

A 58-year-old, non-smoking female of Philippine origin presented with painful thoracic and neck nodal relapse of lung adenocarcinoma almost 5 years after left pneumonectomy for stage II non-small-cell lung cancer. She refused conventional c…

2008
doi:10.1186/1756-9966-27-64 ·PMID:18986516

BackgroundThymidine phosphorylase (TP) is identical with platelet-derived endothelial cell growth factor (PD-ECGF) which promotes angiogenesis. The aim of this study was to evaluate the cytosol activity of TP in tumor samples from patients …